1. Home
  2. CING vs PFSA Comparison

CING vs PFSA Comparison

Compare CING & PFSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CING
  • PFSA
  • Stock Information
  • Founded
  • CING 2012
  • PFSA 2009
  • Country
  • CING United States
  • PFSA United States
  • Employees
  • CING N/A
  • PFSA N/A
  • Industry
  • CING Biotechnology: Pharmaceutical Preparations
  • PFSA Medical/Dental Instruments
  • Sector
  • CING Health Care
  • PFSA Health Care
  • Exchange
  • CING Nasdaq
  • PFSA Nasdaq
  • Market Cap
  • CING 26.7M
  • PFSA 25.1M
  • IPO Year
  • CING 2021
  • PFSA N/A
  • Fundamental
  • Price
  • CING $4.04
  • PFSA $0.50
  • Analyst Decision
  • CING Strong Buy
  • PFSA
  • Analyst Count
  • CING 4
  • PFSA 0
  • Target Price
  • CING $30.67
  • PFSA N/A
  • AVG Volume (30 Days)
  • CING 173.5K
  • PFSA 7.9M
  • Earning Date
  • CING 08-26-2025
  • PFSA 01-01-0001
  • Dividend Yield
  • CING N/A
  • PFSA N/A
  • EPS Growth
  • CING N/A
  • PFSA N/A
  • EPS
  • CING N/A
  • PFSA N/A
  • Revenue
  • CING N/A
  • PFSA $75,000.00
  • Revenue This Year
  • CING N/A
  • PFSA N/A
  • Revenue Next Year
  • CING N/A
  • PFSA N/A
  • P/E Ratio
  • CING N/A
  • PFSA N/A
  • Revenue Growth
  • CING N/A
  • PFSA 150.00
  • 52 Week Low
  • CING $3.02
  • PFSA $0.46
  • 52 Week High
  • CING $20.83
  • PFSA $5.50
  • Technical
  • Relative Strength Index (RSI)
  • CING 40.42
  • PFSA N/A
  • Support Level
  • CING $3.50
  • PFSA N/A
  • Resistance Level
  • CING $4.31
  • PFSA N/A
  • Average True Range (ATR)
  • CING 0.46
  • PFSA 0.00
  • MACD
  • CING -0.15
  • PFSA 0.00
  • Stochastic Oscillator
  • CING 24.11
  • PFSA 0.00

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.

About PFSA Profusa Inc. Common Stock

Profusa Inc is a digital health technology company based in Emeryville, CA, that has developed a real-time, consumer-friendly platform that is designed to measure an individual's biochemistry, be easy to use, be cost-effective, and provide the necessary data to manage chronic disease and health and wellness decisions to improve health outcomes for a large population of potential users. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term.

Share on Social Networks: